†Compared to CENTURION and CONSTELLATION Vision Systems. Based on bench data. **Based on worldwide unit sales of AcrySof ® IQ Vivity and Clareon Vivity IOLs, as of Q4, 2024. “As ophthalmic practices ...
Recent share performance and business snapshot Alcon (SWX:ALC) has drawn attention after a period where the stock is down about 10% over the past month and about 17% over the past 3 months, while the ...
Even during this difficult time of the pandemic, economic uncertainty and social unrest, the Justice Department and the SEC have concluded a major FCPA enforcement action. Novartis and Alcon (which ...
Second quarter and first half operations For the second quarter of 2023, Alcon’s sales were $2.4 billion, an increase of 12% on a constant currency basis, as compared to the same quarter of the ...
Acquisition of ALLY Robotic Cataract Laser Systems strengthens Alcon’s cataract equipment and technology portfolio Next generation technology will be expanded globally, improving the efficiency of ...
Q1 2026 Management View "The first quarter was an important step forward for our new products, demonstrating strong market acceptance and share gains" (CEO & Director David Endicott), adding that ...
GENEVA & LAKE FOREST, Calif.--(BUSINESS WIRE)--Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, and STAAR Surgical Company (NASDAQ: STAA) (“STAAR”), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results